Latest Regulatory News

Syrah Resources has secured an extension to the cure date for an alleged default under its Tesla offtake agreement, pushing the deadline from March to June 2026 as both parties work to resolve outstanding issues.

Neurizon Therapeutics announces the resignation of CEO Dr Michael Thurn, with Executive Chair Sergio Duchini stepping in temporarily as the company embarks on a global hunt for new leadership.

Telix Pharmaceuticals has resubmitted its New Drug Application to the FDA for TLX101-Px (Pixclara®), aiming to advance a novel PET imaging agent for glioma diagnosis. The resubmission addresses prior regulatory concerns with additional data, reinforcing hopes for expedited approval.

Bio-Gene has signed a term sheet with Sumitomo Corporation and Nakashima Trading to introduce its 100% natural insecticide Qcide® to Japan’s $1 billion household pest market, aiming for a late 2026 launch.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

West Cobar Metals has significantly expanded its exploration tenure in NSW’s Cobar district by applying for two new licences, increasing its coverage to around 1,090 km² and unlocking fresh potential for copper, gold, antimony, and silver discoveries.

Galilee Energy has confirmed the final location for its Zydeco-1 well in Louisiana, targeting significant gas and condensate resources with drilling set for the second quarter of 2026. The well also aims to explore additional oil potential, optimising costs and environmental impact.

Prodigy Gold has updated its Hyperion Gold deposit resource, boosting indicated ounces by 70% to 212,000 ounces and increasing the total resource to 454,000 ounces. This reflects successful 2025 drilling and improved confidence ahead of a planned scoping study.

NeuRizer Limited has secured a pivotal partnership with Reliance Industries, enabling it to resolve funding challenges and accelerate its Leigh Creek urea project. This collaboration marks a turning point for the company, allowing it to exit suspension and advance critical regulatory and operational milestones.

Argo Investments Limited has confirmed a fully franked dividend of AUD 0.185 per share for the half-year ending December 2025, alongside updated details on its Dividend Reinvestment Plan and Bonus Security Plan pricing.

MC Mining reports a modest improvement in half-year losses despite declining coal production and revenue, while advancing its Makhado Project and suspending Uitkomst operations to curb cash losses.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.